[ad_1]
Jakarta, CNBC Indonesia – The testing of the final phase (third) of the AstraZeneca vaccine against corona (Covid-19) was stopped since the beginning of this week. The side effect of the poor health of the volunteers from England was the cause.
In the report STAT NewsThe recipient of the vaccine in collaboration with the University of Oxford has a rare but serious neurological disorder of spinal inflammation.
He is said to suffer from transverse myelitis (transverse myelitis), as written by the STAT News media, as quoted by AstraZeneca CEO Pascal Soriot.
Neurology is a disorder of the nervous system. While transverse myelitis is an inflammation of a part of the spinal cord with a number of conditions that accompany it, such as pain, numbness or numbness, weakness in the legs or arms, and alterations in urination and bowel movements.
Still, there are two new facts. First of all, AstraZeneca is still optimistic that its Covid vaccine will be completed by the end of the year. Although, currently clinical trials are temporarily suspended.
“We can still get the vaccine at the end of this year, early next year,” Soriot said.
He stressed that his party would be led by a committee to discuss when testing would restart. So, he said, the company could restart vaccine testing as soon as possible.
AstraZeneca is one of the most advanced Covid-19 vaccine candidates. This vaccine is called AZD1222.
The vaccine uses an adenovirus, which causes the flu, which is designed to encode a protein spike that the corona uses to attack cells. After vaccination, the protein is produced in the human body, which strengthens the immune system to attack the corona virus if the person becomes infected at some point.
Second, the breaks that are taken show the importance of doing vaccine trials correctly. With independent supervision and regulatory participation.
This is emphasized by Jeremy Farrar, director of the British scientific research charity, The Wellcome Trust. “In the end, people must have absolute confidence that the vaccine is safe and certainly effective, and in the end the pandemic is expected to end soon,” he said.
The World Health Organization (WHO) made similar comments. The UN agency’s chief of science, Soumya Swaminathan, said this was important so that people’s safety was a top priority.
“This is good clinical practice because safety is the highest and highest priority in any clinical trial,” he said.
He also emphasized that this is a “wake-up call” and a lesson for all parties. That, research does not always show progress, but there are ups and downs.
There are currently a total of nine candidate vaccines that are entering the final testing stage. In addition to the AstraZeneca vaccine, Russia through Sputnik V and China with Sinovac are also testing the side effects of the vaccine in humans, with the participation of thousands of volunteers from many countries.
[Gambas:Video CNBC](Head to head)
